Biologics Consulting, a full-service regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices, has launched a rebranding effort that includes the introduction of new brand positioning, as well as a new logo and interactive website. In conjunction with the rebranding effort, the company is launching its Expert Edge Webinar Series, an interactive, web-based workshop series hosted by its regulatory and product development consultants. The series will cover a number of relevant topics throughout the year and provide industry professionals with access to its team of renowned consultants.
In the nearly three decades since its founding, Biologics Consulting has professionally served more than 3,500 clients in 53 countries, making it a global leader in regulatory affairs and product development. To position itself for continued growth, the company revealed a new brand identity that reinforces its mission of helping companies of all sizes overcome regulatory and product development challenges. The new look and feel includes a new brand name, logo and website (www.biologicsconsulting.com).
In conjunction with Biologics Consulting’s updated brand identity, the company launched its Expert Edge Webinar Series. Participants will have the opportunity to interact with Biologics Consulting’s specialists, and gain insight from first-hand case studies and advice on best-practices. The goal of the series is to provide participants with guidance from world-leading consultants who can help address some of the most complex challenges in the Industry today.
The first webinar in the series will be presented by Christina Vessely, Ph.D., senior consultant at Biologics Consulting, on February 18th at 3:00 p.m. EST (http://bit.ly/1P2YaJ2). The session, entitled The Value of Analytics for Achieving Successful Manufacturing Process Transfer, will provide guidance and best practices advice from Dr. Vessely on successful manufacturing process transfers. Dr. Vessely will include personal case-studies, as well as an outline of the issues commonly encountered during process transfers and proactive ways to avoid these pitfalls. More webinars will follow throughout the year, each of which will explore relevant regulatory and product development topics.
“This is a very exciting time for our company and we are thrilled to reveal the new look and feel of Biologics Consulting,” commented Norman Baylor, Ph.D., President and CEO of Biologics Consulting. “Our new brand identity ushers in a new era for our growing company and demonstrates our continued passion for and commitment to the work that we do. I am proud of the level of expertise we have in-house and am eager for the opportunity to share it with other industry professionals through our Expert Edge Webinar Series.”
About Biologics Consulting (www.biologicsconsulting.com)
Biologics Consulting Group, Inc. is a full-service regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices. Founded in 1993 by Dr. James Kenimer, who previously served more than 15 years at the Food and Drug Administration (FDA), Biologics Consulting has built a record of achievement, assisting clients worldwide with nonclinical and clinical, product development and regulatory compliance challenges.
Biologics Consulting has served more than 3,500 companies in 53 countries, and in the past four years, it has contributed to more than 50 original INDs, 75 BLAs/NDAs (full and supported), 80 510Ks, and 42 IDEs.
# # #